<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-18329" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Biotin Deficiency</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Saleem</surname>
            <given-names>Fatima</given-names>
          </name>
          <aff>King Edward Medical University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Soos</surname>
            <given-names>Michael P.</given-names>
          </name>
          <aff>McLaren Greater Lansing</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Fatima Saleem declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Michael Soos declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>20</day>
          <month>2</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-18329.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Biotin is a B-complex vitamin that serves as an essential coenzyme for five carboxylases: pyruvate carboxylase, 3-methylcrotonyl-CoA carboxylase, propionyl-CoA carboxylase, and coenzyme for acetyl-CoA carboxylases 1 and 2. Biotin deficiency affects the activity of biotin-dependent carboxylases. These carboxylases facilitate various metabolic reactions, such as gluconeogenesis, fatty acid synthesis, and amino acid metabolism. This activity reviews the evaluation of biotin deficiency and highlights the role of the interprofessional team in evaluating and treating patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of biotin deficiency.</p></list-item><list-item><p>Assess&#x000a0;the evaluation of biotin deficiency.</p></list-item><list-item><p>Evaluate&#x000a0;the management options available for biotin deficiency.</p></list-item><list-item><p>Communicate&#x000a0;interprofessional team strategies for improving care coordination to ensure better outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18329&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18329">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-18329.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Biotin&#x000a0;(vitamin H or vitamin B7) is a B-complex vitamin&#x000a0;that acts as an essential coenzyme&#x000a0;for&#x000a0;5 carboxylases: pyruvate carboxylase, 3-methylcrotonyl-CoA carboxylase, propionyl-CoA carboxylase, and coenzyme for acetyl-CoA carboxylases 1 and 2.<xref ref-type="bibr" rid="article-18329.r1">[1]</xref><xref ref-type="bibr" rid="article-18329.r2">[2]</xref><xref ref-type="bibr" rid="article-18329.r3">[3]</xref><xref ref-type="bibr" rid="article-18329.r4">[4]</xref> These carboxylases help in several chemical processes in the cell, including gluconeogenesis, amino acid metabolism, and fatty acid synthesis.<xref ref-type="bibr" rid="article-18329.r1">[1]</xref><xref ref-type="bibr" rid="article-18329.r3">[3]</xref> The Food and Nutrition Board of the Institute of Medicine recommends a daily dietary intake of 30 mcg/day to maintain good health. Biotin deficiency is rare in those on a normal, balanced diet. Mammals obtain biotin from food. Foods rich in biotin are egg yolk, liver, cereals (wheat, oats), vegetables (spinach, mushrooms), and rice. Dairy items and breast milk also contain biotin. Besides, gut micro bacteria can produce biotin. The average dietary intake of biotin in the Western population is approximately 35 to 70 mcg/day.<xref ref-type="bibr" rid="article-18329.r2">[2]</xref><xref ref-type="bibr" rid="article-18329.r3">[3]</xref><xref ref-type="bibr" rid="article-18329.r5">[5]</xref>&#x000a0;</p>
        <p>Nominal&#x000a0;biotin deficiency&#x000a0;has been noted in&#x000a0;pregnant and lactating women,&#x000a0;but its clinical significance is unknown. Biotin supplements are available in the market for improving nail, hair, and skin health, but there is no robust evidence available. Taking biotin supplements can interfere with some laboratory tests, resulting in false-positive and false-negative results. Studies report the efficacy of high-dose biotin in some neurological conditions, such as multiple sclerosis; however, the underlying mechanism is uncertain.</p>
      </sec>
      <sec id="article-18329.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>There are many causes of biotin deficiency. It can occur in rare inborn errors of metabolism, namely holocarboxylase synthetase deficiency or biotinidase deficiency.<xref ref-type="bibr" rid="article-18329.r5">[5]</xref><xref ref-type="bibr" rid="article-18329.r3">[3]</xref> Biotinidase deficiency is an autosomal recessive disorder. It can present as severe biotin deficiency with&#x000a0;both neurological and dermatological features. It affects endogenous recycling and failure in releasing biotin from dietary protein. This affects the activity of 5 carboxylases that depend on biotin.<xref ref-type="bibr" rid="article-18329.r6">[6]</xref><xref ref-type="bibr" rid="article-18329.r7">[7]</xref> Gastrointestinal tract bacterial imbalances&#x000a0;resulting from&#x000a0;broad-spectrum antibiotics or inflammatory bowel disease can affect biotin synthesis in the intestine and thus lead to biotin deficiency.</p>
        <p>Biotin deficiency can also occur in patients on parenteral nutrition without added biotin.<xref ref-type="bibr" rid="article-18329.r5">[5]</xref><xref ref-type="bibr" rid="article-18329.r1">[1]</xref><xref ref-type="bibr" rid="article-18329.r8">[8]</xref>&#x000a0;Therefore, the recommended daily dose of biotin must be added to total parental nutrition (TPN), particularly if TPN therapy is likely to be given for over a week. Currently, all hospital pharmacies add biotin to TPN preparations.<xref ref-type="bibr" rid="article-18329.r9">[9]</xref><xref ref-type="bibr" rid="article-18329.r1">[1]</xref>&#x000a0;Low Biotin levels can occur in patients on antiepileptics such as carbamazepine, phenytoin, and phenobarbital.&#x000a0;Possible underlying mechanisms include impaired biotin uptake across the intestinal mucosa, exaggerated biotin catabolism, and inhibition of&#x000a0;renal reabsorption. Therefore, patients likely to be on anticonvulsants for a long time should receive biotin supplementation.<xref ref-type="bibr" rid="article-18329.r10">[10]</xref><xref ref-type="bibr" rid="article-18329.r11">[11]</xref>&#x000a0;Prolonged use of oral antibiotics&#x000a0;may also lead to biotin deficiency. The most likely underlying mechanism is the inhibition of intestinal flora, leading to reduced biotin production. Another possible&#x000a0;explanation is&#x000a0;the antibiotic-driven overgrowth of biotin-consuming bacteria.<xref ref-type="bibr" rid="article-18329.r12">[12]</xref></p>
        <p>Likewise, low biotin levels can occur in patients on isotretinoin for acne treatment, elderly individuals, people with alcohol use disorder, and smokers (particularly women).<xref ref-type="bibr" rid="article-18329.r13">[13]</xref>&#x000a0;Some studies have found biotin deficiency&#x000a0;in a large percentage of pregnant and lactating women. Some experts argue that there can be teratogenic effects of decreased biotin levels, and a higher biotin intake should be advised for pregnant women.<xref ref-type="bibr" rid="article-18329.r14">[14]</xref>&#x000a0;Reports exist of biotin deficiency in severely malnourished children in developing countries and through the intake of modified milk without biotin supplementation.&#x000a0;Biotin deficiency has been&#x000a0;observed in infants consuming hypoallergenic formulas.<xref ref-type="bibr" rid="article-18329.r15">[15]</xref>&#x000a0;Consuming large amounts of raw egg whites can lead to acquired biotin deficiency. Raw egg contains the glycoprotein avidin. Avidin binds to biotin in the gastrointestinal tract and prevents biotin absorption, also known as &#x0201c;egg white injury.&#x0201d;<xref ref-type="bibr" rid="article-18329.r1">[1]</xref><xref ref-type="bibr" rid="article-18329.r3">[3]</xref><xref ref-type="bibr" rid="article-18329.r5">[5]</xref><xref ref-type="bibr" rid="article-18329.r16">[16]</xref></p>
      </sec>
      <sec id="article-18329.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Suboptimal biotin levels are common in pregnancy. Despite a normal dietary biotin intake, about half of US pregnant women are marginally deficient. According to the worldwide neonatal screening survey, the incidence of profound biotin deficiency is&#x000a0;1 in 112,271, and the incidence of partial deficiency is&#x000a0;1 in 129,282. The combined incidence of profound and partial deficiency is&#x000a0;1 in 60,089 live births. Biotinidase deficiency has been diagnosed more commonly in children of the White race. Research has observed a higher incidence of biotin deficiency in Brazil, Turkey, and Saudi Arabia.<xref ref-type="bibr" rid="article-18329.r17">[17]</xref><xref ref-type="bibr" rid="article-18329.r6">[6]</xref> People who excessively consume alcohol have a relatively higher incidence of low biotin levels compared to the general population.<xref ref-type="bibr" rid="article-18329.r5">[5]</xref>&#x000a0;</p>
        <p>Worldwide, profound biotinidase deficiency is reported as 1 in 137401; partial biotinidase deficiency is estimated to be 1 in 109,921, and the comprehensive incidence is 1 in 61067. The prevalence is higher in countries with higher rates of consanguinity, such as Saudi Arabia and Turkey. Neto et al reported an incidence of 1 per 9,000 people in Brazil.<xref ref-type="bibr" rid="article-18329.r18">[18]</xref> In the US, biotin deficiency is observed&#x000a0;to be&#x000a0;greater in people of Hispanic origin and lesser in African American population. Holocarboxylase synthetase deficiency is&#x000a0;observed to be 1 in 87,000.</p>
      </sec>
      <sec id="article-18329.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Biotin (B7) has a key role in cellular energy metabolism, including ATP production and regulation of oxidative stress, since it is a crucial cofactor for&#x000a0;5 carboxylases that work for the mitochondrial metabolism of glucose, fatty acids, and amino acids. Holocarboxylase synthetase plays a vital role in protein biotinylation, and protein biotinidase is essential for releasing biotin from biotinylated peptides.<xref ref-type="bibr" rid="article-18329.r1">[1]</xref><xref ref-type="bibr" rid="article-18329.r2">[2]</xref><xref ref-type="bibr" rid="article-18329.r19">[19]</xref>&#x000a0;Current evidence shows that biotin is vital in gene expression and chromatin structure. Approximately 2000 biotin-dependent genes have been identified so far. Biotin is attached to histones, and this histone biotinylation appears to work in transcriptional repression of genes and thus maintains genome stability.<xref ref-type="bibr" rid="article-18329.r1">[1]</xref><xref ref-type="bibr" rid="article-18329.r16">[16]</xref><xref ref-type="bibr" rid="article-18329.r17">[17]</xref>&#x000a0;Biotin also regulates immunological and inflammatory functions. Patients with multiple carboxylase deficiency linked to biotin deficiency have shown defects in B-cell and T-cell immunity. Biotin plays a key role in the function of natural killer lymphocytes and the generation of cytotoxic T lymphocytes. It shows a role in the maturation and responsiveness of immune cells. Evidence shows increasing interleukin-1-beta (IL-1-beta) and proinflammatory cytokines TNF-alpha in biotin deficiency. Biotin levels also affect transcriptional factors, such as NF-kappa B.<xref ref-type="bibr" rid="article-18329.r1">[1]</xref><xref ref-type="bibr" rid="article-18329.r19">[19]</xref>&#x000a0;In addition to the role biotin plays as a cofactor in various carboxylation reactions, recently, it has been observed that biotin plays important roles in gene expression and immune mechanisms.<xref ref-type="bibr" rid="article-18329.r20">[20]</xref><xref ref-type="bibr" rid="article-18329.r19">[19]</xref>&#x000a0;Five biotin-dependent carboxylases exist as inactive apoforms.<xref ref-type="bibr" rid="article-18329.r21">[21]</xref>&#x000a0;These&#x000a0;5 biotin-dependent carboxylases are described below:</p>
        <list list-type="bullet">
          <list-item>
            <p>Pyruvate carboxylase (PC) - catalyzes an important step in the gluconeogenesis, TCA cycle, and lipogenesis</p>
          </list-item>
          <list-item>
            <p>Propionyl-CoA carboxylase&#x000a0;(PCC) - important in the metabolism of amino acids and odd-chain fatty acids</p>
          </list-item>
          <list-item>
            <p>3-Methylcrotonoyl-CoA carboxylase&#x000a0;(MCC) - carries out the catabolism of leucine</p>
          </list-item>
          <list-item>
            <p>Acetyl-CoA carboxylase 1 (ACC 1) -&#x000a0;converts acetyl CoA to malonyl CoA, which is a significant step in lipid synthesis</p>
          </list-item>
          <list-item>
            <p>Acetyl-CoA carboxylase 2 (ACC 2) -&#x000a0;has a regulatory&#x000a0;function in fatty acid oxidation<xref ref-type="bibr" rid="article-18329.r14">[14]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <p>Biotin deficiency can also manifest clinically due to genetic disorders leading to a lack of the enzyme holocarboxylase synthetase, or the individual carboxylase enzymes can be deficient. Biotinylation&#x000a0;of histones may&#x000a0;have an important role in gene expression. Biotin has also been observed to affect gene expression via other mechanisms.&#x000a0;Many biotin-dependent genes have been studied in human cells. Some of these genes encode enzymes involved in glucose metabolism, cytokines like interleukin-2, and insulin receptors.<xref ref-type="bibr" rid="article-18329.r22">[22]</xref> Biotin has been reported to be in&#x000a0;antibody production, differentiation of T and B lymphocytes, macrophage function,&#x000a0;and the normal functioning of natural killer cells.<xref ref-type="bibr" rid="article-18329.r19">[19]</xref> Recurrent infections,&#x000a0;particularly fungal, are commonly seen in patients with biotin deficiency.</p>
      </sec>
      <sec id="article-18329.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Biotin deficiency leads to variable clinical presentations, mainly neurological and dermal abnormalities. Biotinidase deficiency is the commonest etiology; in many countries, including the US, screening for biotinidase deficiency is a part of the newborn screening program. Therefore, the condition is identified in many individuals before symptoms develop. History includes recognizing risk factors for biotin deficiency, such as gastrointestinal or inflammatory bowel disease history. Any history of drug intake that interferes with biotin metabolism or uptake is significant, eg, antiepileptics, antibiotics, or isotretinoin. Dermal abnormalities in biotin deficiency are due to impaired fatty acid metabolism. These include hair loss (alopecia) and periorificial dermatitis; scaly, red rash around the orifices, ie, eyes, nose, and mouth (also called &#x0201c;biotin-deficient face&#x0201d;). The rash is similar to that of zinc deficiency. Patients may also develop conjunctivitis and skin infections.</p>
        <p>Neurological symptoms include hypotonia, seizures, ataxia, numbness, and tingling of the extremities, mental retardation, and developmental delay in children.<xref ref-type="bibr" rid="article-18329.r23">[23]</xref><xref ref-type="bibr" rid="article-18329.r24">[24]</xref><xref ref-type="bibr" rid="article-18329.r25">[25]</xref><xref ref-type="bibr" rid="article-18329.r26">[26]</xref>&#x000a0;The patient may show depression, lethargy, and a history of hallucinations. Other neurological&#x000a0;abnormalities include optic atrophy and sensorineural hearing loss if left untreated.<xref ref-type="bibr" rid="article-18329.r27">[27]</xref>&#x000a0;Intestinal symptoms may also develop in patients with biotin deficiency, such as nausea, vomiting, and anorexia. Other biotin deficiency presentations include ketoacidosis, lactic acidosis, and organic aciduria.<xref ref-type="bibr" rid="article-18329.r28">[28]</xref>&#x000a0;Individuals with hereditary disorders of biotin deficiency, such as biotinidase deficiency, may also show impaired immune system function, leading to increased susceptibility to infections, eg,&#x000a0;<italic toggle="yes">Candida</italic>.&#x000a0;Biotinidase deficiency typically shows symptoms at the age of 1 week to more than&#x000a0;1 year and may have additional symptoms like hearing loss and optic atrophy.</p>
        <p>As observed in swine, initial clinical symptoms of acquired biotin deficiency include gradual onset of hair loss, dry skin, and lesions on the feet and legs after&#x000a0;6 months of biotin deficiency.<xref ref-type="bibr" rid="article-18329.r4">[4]</xref> After&#x000a0;90 months, the clinical picture resembles a characteristic cutaneous lesion of biotin deficiency. After 3 to 4 weeks of having a raw egg diet in adult humans, desquamative dermatitis was observed. After&#x000a0;5 weeks, anorexia, lethargy, and hyperaesthesia developed. Administration of biotin relieved symptoms in 5 days. Infants may initially show mild scaly erythema and dermatitis on the face, particularly malar prominences, which may resemble dermatitis rash due to soaps.&#x000a0;Holocarboxylase synthetase deficiency&#x000a0;can present very early in fetal life in the form of abnormal CNS findings and intrauterine growth retardation.<xref ref-type="bibr" rid="article-18329.r29">[29]</xref>&#x000a0;Once biotin deficiency&#x000a0;is confirmed, a physical exam should be carried out focusing on the extent of the disease. It must include a&#x000a0;thorough neurological exam, developmental assessment (age-appropriate), hearing evaluation, and&#x000a0;visual assessment.</p>
      </sec>
      <sec id="article-18329.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnostic tests for biotin deficiency are urinary 3-hydroxyisovaleric acid and biotin and the status of propionyl-CoA carboxylase in lymphocytes.<xref ref-type="bibr" rid="article-18329.r16">[16]</xref><xref ref-type="bibr" rid="article-18329.r17">[17]</xref> Biotin-dependent carboxylases in human lymphocytes are reliable markers for determining biotin status. Decreased beta-methylcrotonyl-CoA carboxylase activity shunts the catabolism to alternative pathways, leading to the elevated formation of 3-hydroxyisovaleric acid. The most reliable marker of biotin deficiency is increased excretion of 3-hydroxyisovaleric acid in the urine (over 195 micromol/24 hours). Evidence shows that serum biotin concentration does not decrease in biotin deficiency patients receiving biotin-free total parenteral nutrition. Therefore, serum biotin levels are not reliable indicators of marginal biotin deficiency.<xref ref-type="bibr" rid="article-18329.r5">[5]</xref><xref ref-type="bibr" rid="article-18329.r16">[16]</xref> If biotin deficiency is suspected, it warrants a thorough neurological examination and other investigations, including vision and hearing testing. Biotinidase deficiency confirmation is done by DNA analysis, either allele-targeted methods or full-gene sequencing. All newborn screening programs in the U.S. and more than 30 other countries carry out screening for biotinidase deficiency.<xref ref-type="bibr" rid="article-18329.r6">[6]</xref><xref ref-type="bibr" rid="article-18329.r7">[7]</xref><xref ref-type="bibr" rid="article-18329.r30">[30]</xref><xref ref-type="bibr" rid="article-18329.r7">[7]</xref></p>
        <p>Various MRI changes have been reported in individuals with biotinidase deficiency.<xref ref-type="bibr" rid="article-18329.r31">[31]</xref><xref ref-type="bibr" rid="article-18329.r32">[32]</xref>&#x000a0;Desai et al noted MRI findings in&#x000a0;4 patients and observed:</p>
        <list list-type="bullet">
          <list-item>
            <p>Encephalopathy</p>
          </list-item>
          <list-item>
            <p>Low cerebral volume</p>
          </list-item>
          <list-item>
            <p>Ventriculomegaly</p>
          </list-item>
          <list-item>
            <p>Widened extracerebral cerebrospinal fluid spaces</p>
          </list-item>
        </list>
        <p>A&#x000a0;complete reversal of&#x000a0;these findings occurred with biotin use in&#x000a0;2 patients.</p>
      </sec>
      <sec id="article-18329.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Biotin deficiency management essentially means treating the cause. Lifelong treatment with biotin supplements is required in patients with genetic disorders disrupting biotin metabolism, such as&#x000a0;holocarboxylase&#x000a0;synthetase deficiency and biotinidase deficiency. If the deficiency is related to excessive consumption of raw eggs, it should be stopped, and biotin replacement should ensue. Change anticonvulsants if the deficiency is caused by the use of a particular anticonvulsant. Similarly, those on prolonged oral antibiotic therapy may benefit from biotin supplementation. Oral biotin supplements have high bioavailability. Usually, a dose of 5 mg/day is given regardless of the etiology of biotin deficiency.<xref ref-type="bibr" rid="article-18329.r5">[5]</xref>&#x000a0;The Food and Nutrition Board of the National Research Council recommends a range of 5 mcg/day in newborn infants to 35 mcg/day in lactating women. Practitioners should be aware that biotin requirements may increase during anticonvulsant therapy.<xref ref-type="bibr" rid="article-18329.r16">[16]</xref>&#x000a0;In biotinidase deficiency, patient therapy typically consists of lifelong doses of biotin. Biotin doses ranging from 5 to 20 mg can treat and prevent clinical signs and biotinidase deficiency symptoms.<xref ref-type="bibr" rid="article-18329.r7">[7]</xref><xref ref-type="bibr" rid="article-18329.r17">[17]</xref>&#x000a0;In the cases of holocarboxylase synthetase deficiency detected antenatally, antenatal biotin treatment is very useful.<xref ref-type="bibr" rid="article-18329.r29">[29]</xref></p>
      </sec>
      <sec id="article-18329.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The significant differential includes the inborn error of metabolism, such as sodium-dependent multivitamin transporter defect. Sodium-dependent multivitamin transporter defect can cause a metabolic disorder similar to biotinidase deficiency. There is a deficiency of biotin, pantothenic acid, and lipoate.<xref ref-type="bibr" rid="article-18329.r33">[33]</xref> Biotin deficiency can&#x000a0;have a clinical picture similar to acrodermatitis enteropathica (a disorder of zinc metabolism).&#x000a0;Biotin deficiency can present with symptoms similar to zinc deficiency. Biotin is necessary for zinc homeostasis in the skin; the precise nature of this association between zinc and biotin is unknown.<xref ref-type="bibr" rid="article-18329.r3">[3]</xref> The clinician can differentiate zinc deficiency skin rash from biotin deficiency rash as zinc deficiency causes bullous, scaly (scald-like) lesions on facial orifices and friction areas of the body. Zinc deficiency causes angular cheilitis, alopecia, and paronychia.<xref ref-type="bibr" rid="article-18329.r34">[34]</xref></p>
      </sec>
      <sec id="article-18329.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Biotin deficiency is rare and has a relatively good prognosis. Children diagnosed with biotinidase deficiency require early intervention and life-long biotin treatment. Children who quit therapy develop symptoms again within weeks to months. When neonates diagnosed by neonatal screening receive biotin, they develop normally without having any symptoms, and those with symptoms respond quickly to biotin treatment. Failure to evaluate and manage biotinidase deficiency at an early stage can cause irreversible neurodevelopmental abnormalities and lead to developmental delay and autistic behavior.<xref ref-type="bibr" rid="article-18329.r6">[6]</xref><xref ref-type="bibr" rid="article-18329.r7">[7]</xref><xref ref-type="bibr" rid="article-18329.r17">[17]</xref></p>
      </sec>
      <sec id="article-18329.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Since biotin plays a crucial role in maintaining cell-mediated and humoral immunity, biotin deficiency due to inborn metabolism errors can cause skin candidiasis in infants and children. There may be IgA deficiency and low percentages of T lymphocytes. They may have absent delayed-hypersensitivity skin-test responses.<xref ref-type="bibr" rid="article-18329.r16">[16]</xref><xref ref-type="bibr" rid="article-18329.r17">[17]</xref>&#x000a0;Biotin deficiency can cause encephalopathies. Patients usually respond well to large doses of biotin. Evidence shows that a lack of biotin is teratogenic in animal models. Mice with biotin deficiency strains developed fetal malformations, most commonly cleft palate, micrognathia, and micromelia.<xref ref-type="bibr" rid="article-18329.r35">[35]</xref><xref ref-type="bibr" rid="article-18329.r36">[36]</xref></p>
      </sec>
      <sec id="article-18329.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Marginal biotin deficiency is common in pregnancy and&#x000a0;could be attributable to an increased demand for biotin. Likewise, lactation can lead to an increased demand for biotin.<xref ref-type="bibr" rid="article-18329.r16">[16]</xref> Clinical data shows that patients with multiple sclerosis when treated with daily biotin doses of up to 300 mg, respond positively, with a reversal in disease progression&#x000a0;and reducing chronic disability.<xref ref-type="bibr" rid="article-18329.r1">[1]</xref><xref ref-type="bibr" rid="article-18329.r2">[2]</xref> The likely mechanism is due to increased myelin production leading to increased axonal remyelination. Biotin may also increase energy production and decrease axonal hypoxia in multiple sclerosis.<xref ref-type="bibr" rid="article-18329.r2">[2]</xref></p>
      </sec>
      <sec id="article-18329.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Biotin deficiency occurs in severely malnourished children in the developed world, thus creating a global public health problem. Biotinidase screening should be part of the workup of infants or children showing clinical features of the disease; it is a routine part of neonatal screening in many countries.<xref ref-type="bibr" rid="article-18329.r7">[7]</xref><xref ref-type="bibr" rid="article-18329.r17">[17]</xref>&#x000a0;A pediatrician, endocrinologist, and geneticist optimally do management of the disorder. Nurses and pharmacists should educate parents about the appropriate dosage and the need for compliance and not stop taking supplemental biotin unless they are told to stop by their clinician. A dietician or nutritionist may also be part of the management team in the rare instances where dietary insufficiency is the etiology. All these disciplines need to function as an interprofessional healthcare team to manage biotin deficiency and guide the patient to an optimal outcome.</p>
        <p>Biotin supplements are readily available in the market. It is routinely given as a nutritional supplement to treat hair loss and brittle nails. Evidence demonstrates the effectiveness of biotin supplements in splitting brittle nails (onychoschizia, onychoschisis). However, little evidence favors biotin supplementation in hair loss unless it is due to hereditary abnormalities of biotin metabolism or acquired biotin deficiency.<xref ref-type="bibr" rid="article-18329.r5">[5]</xref> Health professionals should take this information into account and educate the patients. A dietary consult is recommended as patients need to know the type of biotin-rich food. Primary care clinicians need to follow these patients, as it often takes months to reverse the symptoms. However, the outcomes are good for patients who remain compliant with treatment.</p>
      </sec>
      <sec id="article-18329.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18329&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18329">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/biotin-deficiency/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=18329">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/18329/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=18329">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-18329.s15">
        <title>References</title>
        <ref id="article-18329.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Agrawal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Agrawal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Said</surname>
                <given-names>HM</given-names>
              </name>
            </person-group>
            <article-title>Biotin deficiency enhances the inflammatory response of human dendritic cells.</article-title>
            <source>Am J Physiol Cell Physiol</source>
            <year>2016</year>
            <month>Sep</month>
            <day>01</day>
            <volume>311</volume>
            <issue>3</issue>
            <fpage>C386</fpage>
            <page-range>C386-91</page-range>
            <pub-id pub-id-type="pmid">27413170</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sedel</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bernard</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mock</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Tourbah</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis.</article-title>
            <source>Neuropharmacology</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>110</volume>
            <issue>Pt B</issue>
            <fpage>644</fpage>
            <page-range>644-653</page-range>
            <pub-id pub-id-type="pmid">26327679</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ogawa</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kinoshita</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shimada</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kawamura</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Biotin Is Required for the Zinc Homeostasis in the Skin.</article-title>
            <source>Nutrients</source>
            <year>2019</year>
            <month>Apr</month>
            <day>24</day>
            <volume>11</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">31022908</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mock</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Skin manifestations of biotin deficiency.</article-title>
            <source>Semin Dermatol</source>
            <year>1991</year>
            <month>Dec</month>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>296</fpage>
            <page-range>296-302</page-range>
            <pub-id pub-id-type="pmid">1764357</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tr&#x000fc;eb</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Serum Biotin Levels in Women Complaining of Hair Loss.</article-title>
            <source>Int J Trichology</source>
            <year>2016</year>
            <season>Apr-Jun</season>
            <volume>8</volume>
            <issue>2</issue>
            <fpage>73</fpage>
            <page-range>73-7</page-range>
            <pub-id pub-id-type="pmid">27601860</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hsu</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Chien</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Hwu</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>IF</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Chou</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>NC</given-names>
              </name>
            </person-group>
            <article-title>Genotypic and phenotypic correlations of biotinidase deficiency in the Chinese population.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2019</year>
            <month>Jan</month>
            <day>07</day>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>6</fpage>
            <pub-id pub-id-type="pmid">30616616</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Strovel</surname>
                <given-names>ET</given-names>
              </name>
              <name>
                <surname>Cowan</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>ERRATUM: Laboratory diagnosis of biotinidase deficiency, 2017 update: a technical standard and guideline of the American College of Medical Genetics and Genomics.</article-title>
            <source>Genet Med</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>20</volume>
            <issue>2</issue>
            <fpage>282</fpage>
            <pub-id pub-id-type="pmid">29240078</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Innis</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Allardyce</surname>
                <given-names>DB</given-names>
              </name>
            </person-group>
            <article-title>Possible biotin deficiency in adults receiving long-term total parenteral nutrition.</article-title>
            <source>Am J Clin Nutr</source>
            <year>1983</year>
            <month>Feb</month>
            <volume>37</volume>
            <issue>2</issue>
            <fpage>185</fpage>
            <page-range>185-7</page-range>
            <pub-id pub-id-type="pmid">6401910</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khalidi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Wesley</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Thoene</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Whitehouse</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Baker</surname>
                <given-names>WL</given-names>
              </name>
            </person-group>
            <article-title>Biotin deficiency in a patient with short bowel syndrome during home parenteral nutrition.</article-title>
            <source>JPEN J Parenter Enteral Nutr</source>
            <year>1984</year>
            <season>May-Jun</season>
            <volume>8</volume>
            <issue>3</issue>
            <fpage>311</fpage>
            <page-range>311-4</page-range>
            <pub-id pub-id-type="pmid">6429370</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krause</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Bonjour</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Berlit</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kochen</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Biotin status of epileptics.</article-title>
            <source>Ann N Y Acad Sci</source>
            <year>1985</year>
            <volume>447</volume>
            <fpage>297</fpage>
            <page-range>297-313</page-range>
            <pub-id pub-id-type="pmid">3925859</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Said</surname>
                <given-names>HM</given-names>
              </name>
            </person-group>
            <article-title>Biotin: biochemical, physiological and clinical aspects.</article-title>
            <source>Subcell Biochem</source>
            <year>2012</year>
            <volume>56</volume>
            <fpage>1</fpage>
            <page-range>1-19</page-range>
            <pub-id pub-id-type="pmid">22116691</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hayashi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mikami</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Miyamoto</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kamada</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mizuno</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Naganuma</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Teratani</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Aoki</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fukuda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Suda</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Hattori</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Amagai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ohyama</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kanai</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Intestinal Dysbiosis and Biotin Deprivation Induce Alopecia through Overgrowth of Lactobacillus murinus in Mice.</article-title>
            <source>Cell Rep</source>
            <year>2017</year>
            <month>Aug</month>
            <day>15</day>
            <volume>20</volume>
            <issue>7</issue>
            <fpage>1513</fpage>
            <page-range>1513-1524</page-range>
            <pub-id pub-id-type="pmid">28813664</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sealey</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Teague</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Stratton</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Mock</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Smoking accelerates biotin catabolism in women.</article-title>
            <source>Am J Clin Nutr</source>
            <year>2004</year>
            <month>Oct</month>
            <volume>80</volume>
            <issue>4</issue>
            <fpage>932</fpage>
            <page-range>932-5</page-range>
            <pub-id pub-id-type="pmid">15447901</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mock</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Biotin: From Nutrition to Therapeutics.</article-title>
            <source>J Nutr</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>147</volume>
            <issue>8</issue>
            <fpage>1487</fpage>
            <page-range>1487-1492</page-range>
            <pub-id pub-id-type="pmid">28701385</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hayashi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tokuriki</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Okuno</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shigematsu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yasushi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Matsuyama</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sawada</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ohshima</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Biotin and carnitine deficiency due to hypoallergenic formula nutrition in infants with milk allergy.</article-title>
            <source>Pediatr Int</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>56</volume>
            <issue>2</issue>
            <fpage>286</fpage>
            <page-range>286-8</page-range>
            <pub-id pub-id-type="pmid">24730636</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zempleni</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wijeratne</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Hassan</surname>
                <given-names>YI</given-names>
              </name>
            </person-group>
            <article-title>Biotin.</article-title>
            <source>Biofactors</source>
            <year>2009</year>
            <season>Jan-Feb</season>
            <volume>35</volume>
            <issue>1</issue>
            <fpage>36</fpage>
            <page-range>36-46</page-range>
            <pub-id pub-id-type="pmid">19319844</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zempleni</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hassan</surname>
                <given-names>YI</given-names>
              </name>
              <name>
                <surname>Wijeratne</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Biotin and biotinidase deficiency.</article-title>
            <source>Expert Rev Endocrinol Metab</source>
            <year>2008</year>
            <month>Nov</month>
            <day>01</day>
            <volume>3</volume>
            <issue>6</issue>
            <fpage>715</fpage>
            <page-range>715-724</page-range>
            <pub-id pub-id-type="pmid">19727438</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Neto</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Schulte</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rubim</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>DeMari</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Castilhos</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Brites</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Giugliani</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Newborn screening for biotinidase deficiency in Brazil: biochemical and molecular characterizations.</article-title>
            <source>Braz J Med Biol Res</source>
            <year>2004</year>
            <month>Mar</month>
            <volume>37</volume>
            <issue>3</issue>
            <fpage>295</fpage>
            <page-range>295-9</page-range>
            <pub-id pub-id-type="pmid">15060693</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuroishi</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Regulation of immunological and inflammatory functions by biotin.</article-title>
            <source>Can J Physiol Pharmacol</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>93</volume>
            <issue>12</issue>
            <fpage>1091</fpage>
            <page-range>1091-6</page-range>
            <pub-id pub-id-type="pmid">26168302</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zempleni</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Teixeira</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Kuroishi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Cordonier</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Baier</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Biotin requirements for DNA damage prevention.</article-title>
            <source>Mutat Res</source>
            <year>2012</year>
            <month>May</month>
            <day>01</day>
            <volume>733</volume>
            <issue>1-2</issue>
            <fpage>58</fpage>
            <page-range>58-60</page-range>
            <pub-id pub-id-type="pmid">21871906</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zempleni</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kuroishi</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Biotin.</article-title>
            <source>Adv Nutr</source>
            <year>2012</year>
            <month>Mar</month>
            <day>01</day>
            <volume>3</volume>
            <issue>2</issue>
            <fpage>213</fpage>
            <page-range>213-4</page-range>
            <pub-id pub-id-type="pmid">22516729</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hassan</surname>
                <given-names>YI</given-names>
              </name>
              <name>
                <surname>Zempleni</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Epigenetic regulation of chromatin structure and gene function by biotin.</article-title>
            <source>J Nutr</source>
            <year>2006</year>
            <month>Jul</month>
            <volume>136</volume>
            <issue>7</issue>
            <fpage>1763</fpage>
            <page-range>1763-5</page-range>
            <pub-id pub-id-type="pmid">16772434</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adhisivam</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mahto</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mahadevan</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Biotin responsive limb weakness.</article-title>
            <source>Indian Pediatr</source>
            <year>2007</year>
            <month>Mar</month>
            <volume>44</volume>
            <issue>3</issue>
            <fpage>228</fpage>
            <page-range>228-30</page-range>
            <pub-id pub-id-type="pmid">17413203</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Komur</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Okuyaz</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ezgu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Atici</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>A girl with spastic tetraparesis associated with biotinidase deficiency.</article-title>
            <source>Eur J Paediatr Neurol</source>
            <year>2011</year>
            <month>Nov</month>
            <volume>15</volume>
            <issue>6</issue>
            <fpage>551</fpage>
            <page-range>551-3</page-range>
            <pub-id pub-id-type="pmid">21571559</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rathi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rathi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Biotinidase deficiency with hypertonia as unusual feature.</article-title>
            <source>Indian Pediatr</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>46</volume>
            <issue>1</issue>
            <fpage>65</fpage>
            <page-range>65-7</page-range>
            <pub-id pub-id-type="pmid">19179722</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Joshi</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Fathalla</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Koul</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Maney</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Bayoumi</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Biotin responsive seizures and encephalopathy due to biotinidase deficiency.</article-title>
            <source>Neurol India</source>
            <year>2010</year>
            <season>Mar-Apr</season>
            <volume>58</volume>
            <issue>2</issue>
            <fpage>323</fpage>
            <page-range>323-4</page-range>
            <pub-id pub-id-type="pmid">20508364</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Genc</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Sivri-Kalkano&#x0011f;lu</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Dursun</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Aydin</surname>
                <given-names>HI</given-names>
              </name>
              <name>
                <surname>Tokatli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sennaroglu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Belgin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Co&#x0015f;kun</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Audiologic findings in children with biotinidase deficiency in Turkey.</article-title>
            <source>Int J Pediatr Otorhinolaryngol</source>
            <year>2007</year>
            <month>Feb</month>
            <volume>71</volume>
            <issue>2</issue>
            <fpage>333</fpage>
            <page-range>333-9</page-range>
            <pub-id pub-id-type="pmid">17161472</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wolf</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Biotinidase deficiency: "if you have to have an inherited metabolic disease, this is the one to have".</article-title>
            <source>Genet Med</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>14</volume>
            <issue>6</issue>
            <fpage>565</fpage>
            <page-range>565-75</page-range>
            <pub-id pub-id-type="pmid">22241090</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bandaralage</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Farnaghi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dulhunty</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Kothari</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Antenatal and postnatal radiologic diagnosis of holocarboxylase synthetase deficiency: a systematic review.</article-title>
            <source>Pediatr Radiol</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>46</volume>
            <issue>3</issue>
            <fpage>357</fpage>
            <page-range>357-64</page-range>
            <pub-id pub-id-type="pmid">26754537</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wolf</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Biotinidase deficiency and our champagne legacy.</article-title>
            <source>Gene</source>
            <year>2016</year>
            <month>Sep</month>
            <day>10</day>
            <volume>589</volume>
            <issue>2</issue>
            <fpage>142</fpage>
            <page-range>142-50</page-range>
            <pub-id pub-id-type="pmid">26456103</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bunch</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Peculiar neuroimaging and electrophysiological findings in a patient with biotinidase deficiency.</article-title>
            <source>Seizure</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>83</fpage>
            <page-range>83-6</page-range>
            <pub-id pub-id-type="pmid">21123088</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Desai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ganesan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hegde</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Biotinidase deficiency: a reversible metabolic encephalopathy. Neuroimaging and MR spectroscopic findings in a series of four patients.</article-title>
            <source>Pediatr Radiol</source>
            <year>2008</year>
            <month>Aug</month>
            <volume>38</volume>
            <issue>8</issue>
            <fpage>848</fpage>
            <page-range>848-56</page-range>
            <pub-id pub-id-type="pmid">18545994</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schwantje</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>de Sain-van der Velden</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jans</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>van Gassen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dorrepaal</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Koop</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Visser</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Genetic defect of the sodium-dependent multivitamin transporter: A treatable disease, mimicking biotinidase deficiency.</article-title>
            <source>JIMD Rep</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>48</volume>
            <issue>1</issue>
            <fpage>11</fpage>
            <page-range>11-14</page-range>
            <pub-id pub-id-type="pmid">31392107</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r34">
          <label>34</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Maxfield</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Shukla</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Crane</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <chapter-title>Zinc Deficiency</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>6</month>
            <day>28</day>
            <pub-id pub-id-type="pmid">29630283</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Misir</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Blair</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Doige</surname>
                <given-names>CE</given-names>
              </name>
            </person-group>
            <article-title>Development of a system for clinical evaluation of the biotin status of sows.</article-title>
            <source>Can Vet J</source>
            <year>1986</year>
            <month>Jan</month>
            <volume>27</volume>
            <issue>1</issue>
            <fpage>6</fpage>
            <page-range>6-12</page-range>
            <pub-id pub-id-type="pmid">17422621</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18329.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>BROWN</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The effect of egg white and crystalline biotin methyl ester on a skin lesion in three infants.</article-title>
            <source>Glasgow Med J</source>
            <year>1948</year>
            <month>Sep</month>
            <volume>29</volume>
            <issue>9</issue>
            <fpage>309</fpage>
            <page-range>309-16</page-range>
            <pub-id pub-id-type="pmid">18884873</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
